| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $0 | 0 | 0 |
Sells | $10,867,061 | 12 | 100 |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | 0 | $0 | 1 | $162,399 | $-162,399 |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | 0 | $0 | 1 | $502,630 | $-502,630 |
| Stapley Marc | director | 0 | $0 | 1 | $787,086 | $-787,086 |
| Gilliam Joseph E | PRESIDENT & COO | 0 | $0 | 4 | $1.73M | $-1.73M |
| Kliman Gilbert H | director | 0 | $0 | 3 | $2.18M | $-2.18M |
| Foley Mark J | director | 0 | $0 | 1 | $2.5M | $-2.5M |
| WEISNER AIMEE S | director | 0 | $0 | 1 | $3M | $-3M |
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.
Over the last 12 months, insiders at Glaukos Corporation have bought $0 and sold $10.87M worth of Glaukos Corporation stock.
On average, over the past 5 years, insiders at Glaukos Corporation have bought $0 and sold $24.56M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,200 shares for transaction amount of $100,128 was made by Gilliam Joseph E () on 2017‑11‑22.
| 2025-03-25 | Sale | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | 1,520 0.0027% | $106.84 | $162,399 | -11.86% | |
| 2025-02-26 | Sale | Foley Mark J | director | 20,687 0.0375% | $120.72 | $2.5M | -21.14% | |
| 2025-02-14 | Sale | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | 3,416 0.0062% | $147.14 | $502,630 | -37.51% | |
| 2024-12-20 | Sale | Gilliam Joseph E | PRESIDENT & COO | 3,328 0.006% | $149.85 | $498,716 | -33.25% | |
| 2024-12-20 | Sale | Kliman Gilbert H | director | 10,000 0.0181% | $150.28 | $1.5M | -33.25% | |
| 2024-12-11 | Sale | Kliman Gilbert H | director | 2,000 0.0037% | $144.01 | $288,020 | -28.46% | |
| 2024-10-30 | Sale | Gilliam Joseph E | PRESIDENT & COO | 2,275 0.0041% | $138.97 | $316,157 | -13.12% | |
| 2024-09-09 | Sale | Kliman Gilbert H | director | 3,000 0.0055% | $130.67 | $392,000 | -1.28% | |
| 2024-08-21 | Sale | Gilliam Joseph E | PRESIDENT & COO | 5,000 0.0091% | $129.36 | $646,791 | -1.29% | |
| 2024-08-15 | Sale | Stapley Marc | director | 6,250 0.0118% | $125.93 | $787,086 | +2.48% | |
| 2024-08-08 | Sale | WEISNER AIMEE S | director | 25,000 0.0453% | $120.00 | $3M | +6.24% | |
| 2024-07-05 | Sale | Gilliam Joseph E | PRESIDENT & COO | 2,250 0.0046% | $121.39 | $273,128 | +3.71% | |
| 2024-06-03 | Sale | Gilliam Joseph E | PRESIDENT & COO | 2,500 0.0049% | $113.50 | $283,751 | +9.84% | |
| 2024-05-30 | Sale | Kliman Gilbert H | director | 5,000 0.01% | $112.00 | $560,000 | +13.46% | |
| 2024-05-15 | Sale | Stapley Marc | director | 6,250 0.0126% | $112.80 | $704,993 | +12.75% | |
| 2024-05-10 | Sale | Gilliam Joseph E | PRESIDENT & COO | 2,395 0.0048% | $110.56 | $264,791 | +13.79% | |
| 2024-05-10 | Sale | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | 316 0.0006% | $110.43 | $34,896 | +13.79% | |
| 2024-05-10 | Sale | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | 353 0.0007% | $110.51 | $39,011 | +13.79% | |
| 2024-05-06 | Sale | Gilliam Joseph E | PRESIDENT & COO | 105 0.0002% | $110.36 | $11,588 | +19.60% | |
| 2024-05-06 | Sale | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | 90 0.0002% | $110.26 | $9,923 | +19.60% |
| Gilliam Joseph E | PRESIDENT & COO | 102169 0.1788% | $10.46M | 1 | 40 | +49.43% |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | 72437 0.1268% | $7.41M | 0 | 1 | |
| Foley Mark J | director | 54249 0.0949% | $5.55M | 0 | 2 | |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | 53431 0.0935% | $5.47M | 0 | 15 | |
| Stapley Marc | director | 34076 0.0596% | $3.49M | 0 | 4 | |
| Kliman Gilbert H | director | 32336 0.0566% | $3.31M | 0 | 11 | |
| WEISNER AIMEE S | director | 30119 0.0527% | $3.08M | 2 | 1 | +57.32% |
| MONTREUX EQUITY PARTNERS IV LP | 10 percent owner | 3209812 5.6174% | $328.49M | 0 | 1 | |
| Calcaterra Chris M. | Chief Operating Officer | 163806 0.2867% | $16.76M | 0 | 15 | |
| Burns Thomas William | CHAIRMAN & CEO | 55835 0.0977% | $5.71M | 1 | 45 | +18.1% |
| VERSANT VENTURES I LLC | 51247 0.0897% | $5.24M | 0 | 1 | ||
| LINK WILLIAM J PHD | director | 15439 0.027% | $1.58M | 0 | 5 | |
| MORE ROBERT J | director | 5000 0.0088% | $511,700.00 | 1 | 0 | <0.0001% |
| HARRISON RICHARD L | 1388 0.0024% | $142,047.92 | 1 | 8 | +18.1% | |
| ORBIMED ADVISORS LLC | director | 0 0% | $0 | 0 | 17 | |
| SILVERSTEIN JONATHAN | director | 0 0% | $0 | 0 | 17 |
| Increased Positions | 178 | +46.6% | 7M | +11.42% |
| Decreased Positions | 173 | -45.29% | 6M | -10.32% |
| New Positions | 57 | New | 2M | New |
| Sold Out Positions | 58 | Sold Out | 2M | Sold Out |
| Total Postitions | 387 | +1.31% | 58M | +1.1% |
| Blackrock, Inc. | $749,625.00 | 15.01% | 8.56M | -240,893 | -2.74% | 2025-03-31 |
| Fmr Llc | $535,451.00 | 10.72% | 6.11M | -472,732 | -7.18% | 2024-12-31 |
| Vanguard Group Inc | $523,467.00 | 10.48% | 5.97M | +101,838 | +1.73% | 2024-12-31 |
| Wellington Management Group Llp | $189,197.00 | 3.79% | 2.16M | -24,227 | -1.11% | 2024-12-31 |
| State Street Corp | $180,774.00 | 3.62% | 2.06M | +108,950 | +5.57% | 2024-12-31 |
| Ameriprise Financial Inc | $169,160.00 | 3.39% | 1.93M | +290,661 | +17.72% | 2024-12-31 |
| Invesco Ltd. | $127,791.00 | 2.56% | 1.46M | +68,310 | +4.91% | 2024-12-31 |
| Brown Capital Management Llc | $118,086.00 | 2.37% | 1.35M | -286,734 | -17.54% | 2024-12-31 |
| Lord, Abbett & Co. Llc | $114,726.00 | 2.3% | 1.31M | -219,009 | -14.33% | 2024-12-31 |
| Primecap Management Co/Ca/ | $106,387.00 | 2.13% | 1.21M | -30,860 | -2.48% | 2024-12-31 |